Tc-99m Sestamibi Myocardial Perfusion Imaging After Coronary Artery Bypass Grafting for Ischemic Heart Failure

Authors

  • Li Zhang Department of Cardiovascular Surgery, Yan’an Affiliated Hospital of Kunming Medical University, Kunming, China
  • Jian Wu Department of Cardiovascular Surgery, Yan’an Affiliated Hospital of Kunming Medical University, Kunming, China
  • Yaxiong Li Department of Cardiovascular Surgery, Yan’an Affiliated Hospital of Kunming Medical University, Kunming, China
  • Yaxiong Li Yan’an Affiliated Hospital of Kunming Medical University

DOI:

https://doi.org/10.1532/hsf.4929

Keywords:

ischemic heart failure, Tc-99m MIBI myocardial perfusion imaging, coronary artery bypass grafting

Abstract

Heart failure (HF), a clinical syndrome most commonly occurring due to ischemic heart disease, causes significant morbidity and mortality. The benefits of revascularization versus medical treatment for ischemic heart failure remain controversial. Thus, we assessed a patient diagnosed with ischemic heart failure before and 3 months after coronary artery bypass grafting by myocardial radionuclide imaging. Findings of Tc-99m sestamibi myocardial perfusion imaging revealed that the degree and area of ischemia were significantly reduced, and the systolic function of the left ventricle improved compared with the preoperative value. This suggests the benefit of revascularization in cases of ischemic heart failure.

References

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A. 2021. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, European heart journal. 42(36) 3599-3726.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO. 2018. [2018 ESC/EACTS Guidelines on myocardial revascularization], Kardiol Pol. 76(12) 1585-1664.

Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. 2020. Myocardial ischemia and coronary disease in heart failure, Heart failure reviews. 25(1) 53-65.

Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL. 2016. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy, The New England journal of medicine. 374(16) 1511-20.

Wolff G, Dimitroulis D, Andreotti F, Kołodziejczak M, Jung C, Scicchitano P, Devito F, Zito A, Occhipinti M, Castiglioni B, Calveri G, Maisano F, Ciccone MM, De Servi S, Navarese EP. 2017. Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis, Circ. Heart Fail. 10(1).

Published

2022-09-12

How to Cite

Zhang, L., Wu, J., Li, Y., & Li, Y. (2022). Tc-99m Sestamibi Myocardial Perfusion Imaging After Coronary Artery Bypass Grafting for Ischemic Heart Failure. The Heart Surgery Forum, 25(5), E634-637. https://doi.org/10.1532/hsf.4929

Issue

Section

Articles